quinta-feira, 6 de abril de 2017

SURTAVI

In patients with severe, symptomatic aortic stenosis, transcatheter aortic-valve replacement has become the preferred therapy for those at high surgical risk; efficacy and safety in lower-risk patients are unclear. 

http://www.nejm.org/do/10.1056/NEJMdo005133/full/?query=featured_home